PIONEER SCIENCE. REVOLUTIONIZE MEDICINE. BUILD A LEGACY. Trademark

Trademark Overview

On Wednesday, July 1, 2015, a trademark application was filed for PIONEER SCIENCE. REVOLUTIONIZE MEDICINE. BUILD A LEGACY. with the United States Patent and Trademark Office. The USPTO has given the PIONEER SCIENCE. REVOLUTIONIZE MEDICINE. BUILD A LEGACY. trademark a serial number of 86680598. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 4, 2024. This trademark is owned by Alnylam Pharmaceuticals, Inc.. The PIONEER SCIENCE. REVOLUTIONIZE MEDICINE. BUILD A LEGACY. trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research, scientific research in the fields of pharmaceuticals and medicine, chemical and medical laboratories
pioneer science. revolutionize medicine. build a legacy.

General Information

Serial Number86680598
Word MarkPIONEER SCIENCE. REVOLUTIONIZE MEDICINE. BUILD A LEGACY.
Filing DateWednesday, July 1, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 4, 2024
Registration Number5428785
Registration DateTuesday, March 20, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 17, 2015

Trademark Statements

Goods and ServicesScientific research, scientific research in the fields of pharmaceuticals and medicine, chemical and medical laboratories

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 4, 2024
Primary Code042
First Use Anywhere DateSaturday, February 20, 2016
First Use In Commerce DateSaturday, February 20, 2016

Trademark Owner History

Party NameAlnylam Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142
Party NameAlnylam Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameAlnylam Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Saturday, July 4, 2015NEW APPLICATION ENTERED
Saturday, October 10, 2015ASSIGNED TO EXAMINER
Tuesday, July 7, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 11, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, January 11, 2017SOU EXTENSION 2 FILED
Wednesday, January 11, 2017SOU EXTENSION 2 GRANTED
Saturday, October 10, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 28, 2015NOTICE OF PUBLICATION
Tuesday, November 17, 2015PUBLISHED FOR OPPOSITION
Tuesday, January 12, 2016NOA MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 6, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, July 6, 2016SOU EXTENSION 1 FILED
Wednesday, July 6, 2016SOU EXTENSION 1 GRANTED
Friday, July 8, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Wednesday, July 12, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Wednesday, January 10, 2018SOU TEAS EXTENSION RECEIVED
Friday, January 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, January 22, 2018TEAS STATEMENT OF USE RECEIVED
Friday, January 13, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, July 10, 2017SOU TEAS EXTENSION RECEIVED
Monday, July 10, 2017SOU EXTENSION 3 FILED
Monday, July 10, 2017SOU EXTENSION 3 GRANTED
Wednesday, January 10, 2018SOU EXTENSION 4 FILED
Wednesday, January 10, 2018SOU EXTENSION 4 GRANTED
Monday, January 22, 2018USE AMENDMENT FILED
Thursday, February 1, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 1, 2018STATEMENT OF USE PROCESSING COMPLETE
Sunday, February 11, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 13, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
Tuesday, March 20, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, March 23, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 23, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 23, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 23, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 23, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 20, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, March 30, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 30, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 30, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 4, 2024CANCELLED SEC. 8 (6-YR)

Related Keywords

build legacy medicine revolutionize science pioneer scientific research medical laboratories chemical pharmaceuticals fields